Advertisement

Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 600x60px
Document › Details

ImaBiotech S.A.S.. (7/10/13). "Press Release: Servier and ImaBiotech Collaboration for the Implementation of a MALDI Imaging Platform Using Quantinetix Software". Lille.

Organisation Organisation ImaBiotech S.A.S.
  Group ImaBiotech (Group)
Products Product Quantinetix™ software for quantitative MALDI imaging
  Product 2 mass spectrometry imaging (MSI) (MALDI imaging)
Person Person Stauber, Jonathan (ImaBiotech 201206 CEO)
     


French pharmaceutical company Servier collaborates with ImaBiotech on mass spectrometric derived Imaging technologies in the ADME field.


ImaBiotech, a leading service provider for MALDI imaging has tackled quantification challenges via the development of specially adapted quantification methods and dedicated software, Quantinetix™. Quantitative MALDI imaging technology has the capability to study quantitatively the distribution of drug and metabolites without the need for any labeling. This technology accelerates drug pharmacokinetics and toxicity studies, resulting in a better and faster drug selection for clinical phase. After months of collaboration, Servier acquired ImaBiotech’s Technology of Quantitative MALDI imaging, using Quantinetix Software.

Servier has recently acquired and implemented a quantitative MALDI imaging platform. ImaBiotech has provided guidance about the installation process and the analytical workflow, from sample preparation to quantification.

Dr Mathieu GAUDIN, Team Leader at Servier, says: “ImaBiotech successfully provided us with quantitative MALDI imaging services for drug distribution studies. Using their Quantinetix™ software, we are now able to analyze data
from our MALDI imaging and LESA profiling platforms with absolute quantification.”

Dr Jonathan Stauber, CEO of ImaBiotech adds, ”We are very pleased with the collaboration with Servier. This efficient support further confirms the expertise of ImaBiotech in the ADME field and validates the benefits of the Quantinetix technology.”


Jonathan Stauber, PhD, ImaBiotech
Chief Scientific Officer
E: contact@imabiotech.com
T:+33 (0) 320 164 090


Note: Quantitative MALDI imaging systems and solutions are for research use only (RUO).

   
Record changed: 2016-03-28

Advertisement

Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 600x60px

More documents for ImaBiotech (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px